Overview

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Status:
Completed
Trial end date:
2016-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
Phase:
Phase 3
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Anticonvulsants
Ethosuximide
Lamotrigine
Valproic Acid